3 studies found for: (lymphoma [CONDITION] OR CLL [CONDITION]) AND YM155 [TREATMENT]
Study of YM155 in Refractory Diffuse Large B-cell Lymphoma (DLBCL) Subjects
A Study of YM155 Plus Rituximab in Subjects With Non-Hodgkin's Lymphoma Who Have Received Prior Treatment
An Extension Study Administering YM155 to Subjects Previously Enrolled in Another Protocol Administering YM155
† Study has passed its completion date and status has not been verified in more than two years.